GHR Foundation
  • Domains of Work
    • Global >
      • Children in Families
      • Prepare The Future
    • Local >
      • Catholic Education
      • Twin Cities Racial Equity (TCRE)
    • Biomedical >
      • Alzheimer's Initiative
  • News
  • About Us
    • The Foundation
    • History & Legacy
    • Team >
      • Staff
      • Committees
      • Board
    • Programs in Transition >
      • BridgeBuilder >
        • Overview
        • 2017 Top Ideas >
          • Peace Direct
          • BioCarbon Engineering
          • LIFT Chicago
          • Local Youth Corner Cameroon
          • NaTakallam
        • 2018 Top Ideas >
          • This is My Backyard
          • Found in Translation
          • Producers Direct
          • War Child Canada
          • My Choices Foundation
        • 2019 Top Ideas >
          • Top Manta
          • Five One Labs
          • SAMA for All
          • Talent Beyond Boundaries
          • FaithAction
      • Inter-Religious Action
      • Sister Support
    • FAQs
    • Grants & Financials
  • Contact

GHR Partner Religions for Peace Supporting Multi-Religious Actions on COVID-19 in 20 countries

8/21/2020

0 Comments

 
Picture
Image: Religions for Peace
Religions for Peace’s Multi-Religious Humanitarian Fund, seed-funded by GHR, is bringing together diverse religious leaders, communities, and institutions through affiliated Interreligious Councils to provide critical humanitarian response in the wake of COVID-19. The MRHF is currently financing 20 projects in 20 countries, and RfP announced a new round of applications on August 19th, World Humanitarian Day.

Funded projects were selected based on a track record of interreligious collaboration and experience providing humanitarian relief. Creative proposals raising resources to scale up services, partner with other religious and civic groups, and ensure sustainability of efforts were specifically sought.

Read more...
0 Comments

GHR Commits $1M to COVID-19 Therapeutics Accelerator

8/11/2020

0 Comments

 
Picture
GHR is partnering boldly as we work to address the long-term effects of the COVID-19 pandemic on our partners and communities. Via a $1 million gift, the Foundation joins the Bill & Melinda Gates Foundation, Mastercard Impact Fund and Wellcome in supporting a collaborative effort to research, develop and bring effective COVID-19 treatments to market quickly and accessibly.  

Building off the momentum across public and private sectors to achieve optimal outcomes for therapeutic solutions, the COVID-19 Therapeutics Accelerator (CTA) aims to fill gaps in the R&D ecosystem, remove barriers to drug development and scale up treatments to address the pandemic, particularly in low-resource settings. CTA is committed to equitable access, ensuring that supported innovations are available and affordable to all.  

The immediate focus of this initiative is to develop therapies that mitigate the impact of COVID-19 and can be made available within this year, while leaving a sustainable infrastructure in place for the long term, ensuring future epidemic and pandemic preparedness.  
0 Comments

Partnering Boldly with La Jolla Institute for Immunology on COVID-19 Research

8/3/2020

0 Comments

 
UPDATE 09/17/20: On August 20th, Dr. Saphire's  presented GHR-sponsored work to the Neutralizing Antibody Summit held by Operation Warp Speed. Dr. Francis Collins, the Director of the National Institutes of Health, and all of Operation Warp Speed and NIH are now relying on the data by the La Jolla Institute for Immunology.

GHR is honored to provide $1 million in support of the Coronavirus Immunotherapy Consortium (CoVIC), a global partnership headquartered at the La Jolla Institute for Immunology (LJI). Led by Dr. Erica Ollmann Saphire, Ph.D., a professor in LJI’s Center for Infectious Disease and Vaccine Research, CoVIC aims to accelerate the discovery, optimization, and delivery of life-saving antibody-based therapeutics against SARS-CoV-2, the virus that causes COVID-19. 

“As the COVID-19 pandemic has shown clearly, infectious disease anywhere becomes infectious disease everywhere. Until a vaccine becomes available, we need a way of giving people immediate immunity,” says Dr. Saphire, “and antibody therapy is the way to do it. The support of GHR will help us expand and accelerate the analysis of antibodies from people who have recovered from COVID-19, to understand how they work and deliver the best ones across the globe.” 
GHR LJI Partnership Press Release
File Size: 77 kb
File Type: pdf
Download File

0 Comments

    Categories

    All
    A4
    Alzheimer's
    Alzheimer's Association
    BridgeBuilder
    C2N
    Catholic Schools
    Children In Families
    COVID-19
    Develop Diagnostics
    DIAN Primary Prevention
    DIAN-TU
    Education
    Global Development
    Higher Education
    Inter-Religious Action
    La Jolla Institute
    Mayo Clinic
    Mayo Clinic Study Of Aging
    NIH-NIA
    Observational Studies
    Prepare The Future
    Prevention Trials
    Safeguarding
    Sister Support
    Twin Cities Racial Equity

    RSS Feed

CONNECT WITH US

NEWS  |  JOBS  | ​ CONTACT  
Privacy Policy  |  Terms of Use
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
©2023 GHR FOUNDATION
All Rights Reserved.